Health
Enveric Biosciences Announces $5 Million Public Offering, Raising Questions About Market Impact
Enveric Biosciences (NASDAQ: ENVB), a biotechnology company specializing in neuroplastogenic therapeutics for anxiety, depression, and addiction disorders, has priced a $5 million public offering, a move that highlights both funding needs and potential shareholder dilution concerns. The offering consists of…
Unveiling the Genetic Secrets Behind Coffee’s Bitterness: Why It Tastes Different to Everyone
The age-old debate about why coffee tastes differently to different people has taken a fascinating turn thanks to groundbreaking research conducted at the Leibniz Institute for Food Systems Biology at the Technical University of Munich. The study not only sheds…
Natera Announces Breakthrough Results from Phase III Colorectal Cancer Trial
Natera (NASDAQ: NTRA) has announced successful results from the Phase III CALGB/SWOG 80702 clinical trial for colorectal cancer (CRC) treatment. The trial, involving approximately 1,000 patients, demonstrated that Signatera-positive patients treated with a combination of chemotherapy and celecoxib showed a 40% improvement in overall survival compared to those treated with…
Apellis Pharmaceuticals Strengthens Position in Rare Disease Treatment with $709 Million Revenue in 2024
Apellis Pharmaceuticals, a global biopharmaceutical leader, has closed 2024 with robust financial results, reporting $709 million in U.S. net product revenues. This impressive performance reflects the success of SYFOVRE®, its groundbreaking treatment for geographic atrophy (GA), which generated $611 million…
Genetic Surveillance: Revolutionizing Pathogen Tracking and Infectious Disease Monitoring
The global health landscape is on the brink of a transformative shift with the development of a cutting-edge method for identifying and tracking infectious disease variants in real time. This groundbreaking approach, blending genetic sequencing with advanced analytical tools, has…
$DNA Cryptocurrency by Muhdo Health: Revolutionizing Personalized Healthcare
Muhdo Health’s $DNA cryptocurrency aims to transform healthcare by merging genetic data, artificial intelligence, and blockchain technology. The token empowers users to control their genetic data, receive personalized health recommendations, and monetize their data by sharing it for research under…
Short-Term Cognitive Boost From Exercise May Last for 24 Hours
A new study led by researchers from University College London (UCL) suggests that the short-term cognitive boost following exercise can last up to the next day. Published in the International Journal of Behavioral Nutrition and Physical Activity, the study observed…
How Stress Alters Memory and Unlocks Potential PTSD Treatments
Stress plays a pivotal role in shaping how the brain encodes and retrieves aversive memories, with profound implications for individuals with post-traumatic stress disorder (PTSD). A groundbreaking study from The Hospital for Sick Children (SickKids) reveals how stress-induced memory generalization…
Hidden Fat Predicts Alzheimer’s 20 Years Before Symptoms
Researchers have identified a link between specific types of hidden body fat and the accumulation of abnormal proteins in the brain that signify Alzheimer’s disease. This association appears up to 20 years before the first signs of dementia, according to…
Prolonged Standing at Work May Harm Blood Pressure
A Finnish study from the University of Turku has revealed that prolonged standing at work negatively affects 24-hour blood pressure, potentially increasing the risk of cardiovascular issues. In contrast, more time spent sitting at work was associated with better blood…
Food Allergy Anxiety at 30,000 Feet
Flying with food allergies remains a daunting challenge for millions of individuals and families worldwide, as revealed in a new study from Northwestern University’s Center for Food Allergy and Asthma Research (CFAAR). Published in The Journal of Allergy and Clinical…















